Investigating the role of Ly6h in Alzheimer's disease

The contribution of Ly6h to Alzheimers Disease

NIH-funded research University of California, San Diego · NIH-10754945

This study is looking at a protein called Ly6h to see how it affects brain function in people with Alzheimer's disease, hoping to find new ways to help improve memory and thinking skills.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego NIH-funded
Lab location1 site (La Jolla, United States)
Project IDNIH-10754945 on NIH RePORTER

What this research studies

This research explores how Ly6h, a protein that inhibits certain receptors in the brain, contributes to the development of Alzheimer's disease. The study will examine the relationship between Ly6h levels and cognitive impairment in Alzheimer's patients, as well as how changes in Ly6h affect brain signaling in animal models. Researchers will use various behavioral tests to assess cognitive function and conduct experiments on neurons to understand the underlying mechanisms. The goal is to uncover new insights that could lead to targeted therapies for Alzheimer's disease.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk of developing it.

Not a fit: Patients with other forms of dementia or cognitive impairment unrelated to Alzheimer's disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new biomarkers for early detection and novel treatments for Alzheimer's disease.

How similar studies have performed: Previous research has shown promising results in understanding the role of cholinergic signaling in Alzheimer's disease, suggesting that this approach could yield valuable insights.

Where this research is happening

La Jolla, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer's disease modelAlzheimer's disease pathology
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.